[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360431-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360431-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","setd8-promotes-ovarian-clear-cell-carcinoma-by-epigenetically-activating-rna-metabolism-genes-via-h4k20me1","SETD8 promotes ovarian clear cell carcinoma by epigenetically activating RNA metabolism genes via H4K20me1","","Ovarian clear cell carcinoma (OCCC) is a chemoresistant epithelial cancer with limited options and distinctive molecular traits. Histone methyltransferase SETD8 writes the H4K20me1 mark and, in OCCC, supports transcription of RNA processing genes such as HNRNPA2B1, EIF4G1, and SRSF3 independently of p53. SETD8 inhibition or knockdown reduces H4K20me1, impairs proliferation, and triggers ferroptotic stress with lipid peroxidation. Transcriptomics shows ferroptosis gene reprogramming, while public datasets confirm higher SETD8 expression and worse survival in clear cell tumors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/setd8-promotes-ovarian-clear-cell-carcinoma-by-epigenetically-activating-rna-metabolism-genes-via-h4k20me1/360431/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/setd8-promotes-ovarian-clear-cell-carcinoma-by-epigenetically-activating-rna-metabolism-genes-via-h4k20me1/360431.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SETD8 play in ovarian clear cell carcinoma?","Question",{"text":63,"@type":64},"SETD8 maintains OCCC gene expression programs that support RNA processing and antioxidant defense, thereby supporting cell viability.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SETD8 inhibition affect H4K20me1 and cell growth?",{"text":68,"@type":64},"Pharmacological inhibition or SETD8 knockdown markedly reduces global H4K20me1 levels, suppresses cellular proliferation, and increases lipid peroxidation.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence links SETD8 to ferroptosis in OCCC?",{"text":72,"@type":64},"Inhibition of SETD8 reprograms ferroptosis-associated gene expression and sensitizes cells to ferroptotic stress, consistent with ferroptosis driven by lipid peroxidation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360431,1790384800,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSETD8 promotes ovarian clear cell carcinoma by epigenetically activating RNA metabolism genes via H4K20me1  \nEri Suzuki-Ariyoshi1,5, Syuzo Kaneko2,3,5􀀍, Kenbun Sone1􀀍, Noriko Ikawa2, Ryuta Hachijo1, Yuri Jonouchi1, NatsumiTsuboyama1, Ayumi Taguchi1, Ken Asada2,3, Masaaki Komatsu2,3, Takayuki Iriyama1, Katsutoshi Oda4, Yutaka Osuga1, Yasushi Hirota1 & Ryuji Hamamoto2,3  \nOvarian clear cell carcinoma (OCCC) is a chemoresistant subtype of epithelial ovarian cancer with limited therapeutic options and distinct molecular features. Histone methyltransferase SETD8 catalyzes the monomethylation of histone H4 at lysine 20 (H4K20me1) and has been implicated in transcriptional regulation across multiple cancer types. In endometrial cancer, we previously demonstrated that SETD8 regulates downstream targets through integrative ChIP-seq and RNAseq analyses, linking its activity to p53-dependent signaling pathways. However, the role of SETD8 in OCCC and its potential tumor-context–specific functions remain undefined. Integrative analyses of ChIP-seq and RNA-seq inOCCC revealed that SETD8 maintains the expression of genes critical for RNA processing, including HNRNPA2B1, EIF4G1, and SRSF3, in a manner independent of p53 signaling. Pharmacological inhibition or RNA interference–mediated depletion of SETD8 resulted in a pronounced reduction of global H4K20me1 levels, impaired cellular proliferation, and increased lipid peroxidation consistent with ferroptotic stress. Transcriptomic profiling further demonstrated that SETD8 inhibition reprograms ferroptosis-associated gene expression, establishing a mechanistic link between chromatin-based transcriptional control and cellular redox vulnerability. Furthermore, clinical data analysis from public datasets (GSE29450 and TCGA-KIRC) confirmed that SETD8 is significantly overexpressed inOCCC tissues compared to normal counterparts and that high SETD8 expression correlates with poor overall survival in clear cell lineage tumors, underscoring its potential as a clinical biomarker. Our study provides an in vitro mechanistic framework in which SETD8 safeguards RNA metabolic integrity and mitigates ferroptotic stress through epigenetic regulation in OCCC. These results underscore the lineage-specific roles of SETD8 across gynecologic malignancies and identify SETD8 as a potential therapeutic vulnerability that warrants further in vivo investigation.  \nKeywords SETD8, H4K20me1, Ovarian clear cell carcinoma, Ferroptosis, RNA processing, Epigenetics, p53-independent signaling  \nOvarian clear cell carcinoma (OCCC) is an aggressive histologic subtype of epithelial ovarian cancer characterized by intrinsic resistance to platinum-based chemotherapy and a high prevalence in East Asian populations1–4. Genetically, OCCC is distinct from high-grade serous carcinoma, frequently harboring ARID1A loss-offunction and PIK3CA activating mutations5,6. Despite these molecular insights, effective targeted therapies remain limited, necessitating the identification of novel therapeutic vulnerabilities7,8.  \nHistone methyltransferase SETD8 (KMT5A) catalyzes the monomethylation of histone H4 at lysine 20 (H4K20me1), regulating DNA replication and the DNA damage response9–11. While SETD8 is overexpressed and associated with poor prognosis in various malignancies, its role in OCCC remains undefined12, 13. We previously reported that SETD8 regulates p53-dependent signaling in endometrial cancer14. However, the  \n1Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113- 8655, Japan. 2Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. 3AI Medical Engineering Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan. 4Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, T","cbCaipd54nwSWdvU","https://ap.wps.com/l/cbCaipd54nwSWdvU","pdf",5395062,13,"English","# Results\n## Integrated profiling of SETD8 targets","[{\"question\":\"What role does SETD8 play in ovarian clear cell carcinoma?\",\"answer\":\"SETD8 maintains OCCC gene expression programs that support RNA processing and antioxidant defense, thereby supporting cell viability.\"},{\"question\":\"How does SETD8 inhibition affect H4K20me1 and cell growth?\",\"answer\":\"Pharmacological inhibition or SETD8 knockdown markedly reduces global H4K20me1 levels, suppresses cellular proliferation, and increases lipid peroxidation.\"},{\"question\":\"What evidence links SETD8 to ferroptosis in OCCC?\",\"answer\":\"Inhibition of SETD8 reprograms ferroptosis-associated gene expression and sensitizes cells to ferroptotic stress, consistent with ferroptosis driven by lipid peroxidation.\"}]","SETD8 promotes ovarian clear cell carcinoma by epigenetically activating RNA metabolism genes via H4K20me1 | PDF",1790140094,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbcb49975204d222a9d96397e23efb33.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85ed4c28047df8e2213268da3e0131c7.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48d5d9618b9e5d418ab8657c71447bea.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14d96f1550a9746a776ff71774472ffc.webp",980,1287]